# Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/frequency-of-t790m-mutations-after-progression-on-epidermal-growth-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Venkata Pradeep Babu Koyyala,Ullas Batra,Parveen Jain,Mansi Sharma,Pankaj Goyal,P. Medisetty,Ankush Jajodia,Udip Maheshwari |
| Citations | 12 |
| DOI | 10.4103/lungindia.lungindia_451_17 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://doi.org/10.4103/lungindia.lungindia_451_17 |
| OpenAlex ID | https://openalex.org/W2888871862 |
| PMID | 30168457 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Mansi Sharma](https://scholariq.org/researchers/mansi-sharma/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.